Gradient Denervation Technologies
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $19M
Investors
- 3
About Gradient Denervation Technologies
Founded in 2020, Gradient Denervation Technologies specializes in creating medical solutions for pulmonary hypertension.Gradient Denervation Technologies develops innovative medical devices aimed at treating pulmonary hypertension, notably the Gradient device. This investigational product targets specific physiological mechanisms associated with pulmonary hypertension, aiming to enhance the quality of life for patients. The company serves healthcare providers and research institutions across various regions, focusing on areas where pulmonary hypertension is prevalent.Gradient Denervation Technologies has not disclosed specific revenue figures or transaction structures. However, their business model likely involves partnerships with healthcare institutions and research organizations for the development and potential commercialization of their device. Sales may be structured through B2B agreements, allowing healthcare providers access to the Gradient device via collaborative partnerships or clinical trials. The company aims to introduce new solutions for pulmonary hypertension and will focus on expanding its presence in specific regions affected by this condition. Targeted geographic regions for expansion will be detailed as strategies evolve.
Who invested in Gradient Denervation Technologies
3 investors across 2 rounds
See all investors in Gradient Denervation Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gradient Denervation Technologies
Who invested in Gradient Denervation Technologies?
Gradient Denervation Technologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gradient Denervation Technologies raised?
Gradient Denervation Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gradient Denervation Technologies last raise money?
Gradient Denervation Technologies's most recent round on record is a Series A, in Sep 2023.
What does Gradient Denervation Technologies do?
Founded in 2020, Gradient Denervation Technologies specializes in creating medical solutions for pulmonary hypertension.
Where is Gradient Denervation Technologies headquartered?
Gradient Denervation Technologies is headquartered in Paris, France.
Which VCs invest in companies like Gradient Denervation Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Gradient Denervation Technologies's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Gradient Denervation Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.